Compounded vs Brand-Name GLP-1s: What You're Actually Paying For

A brand-name GLP-1 - Wegovy, Zepbound, Ozempic - is made by the manufacturer, approved by the FDA and sold in standardized pens or pills. A compounded GLP-1 is prepared by a state-licensed pharmacy using the same active ingredient (semaglutide or tirzepatide), usually in vials you draw up with a syringe. It is not FDA-approved: the FDA does not review compounded drugs for safety, effectiveness or quality before they reach you.

So the price gap - often more than $1,000 a month - is paying for regulatory review, manufacturing consistency and a product that insurance may cover. Whether that is worth it depends on your budget, your coverage and how much uncertainty you are comfortable with.

• FDA approval and oversight. The product was tested in large clinical trials, and its manufacturing is inspected. The trial results you read about - such as around 15% average weight loss in STEP-1 and about 21% in SURMOUNT-1 - were achieved with the approved products.
• Consistency. Every pen contains exactly the labeled dose in a fixed device. No vials, no drawing up doses.
• Insurance eligibility. Only brand-name medication can be billed to insurance. If your plan covers it, your out-of-pocket cost can be far lower than any cash price.
• Legal clarity. You are not relying on a compounding exemption that regulators are still actively shaping.

For scale, self-pay brand-name list prices on the platforms we track include Ozempic at $1,149/mo, Zepbound at $1,249/mo and Wegovy at $1,579/mo (altRx), or Ozempic at $1,399/mo and Zepbound at $1,599/mo (wellmedr).

The obvious win is price. Compounded semaglutide on our list runs from $49/mo (wellmedr, 12-month plan) to $149/mo (trimrx), and compounded tirzepatide from $89/mo (wellmedr) to $259/mo (trimrx). Many programs also bundle the clinician visits, messaging and shipping into that price, and some allow custom dosing that fixed brand pens don't.

What you give up is independent verification. Quality depends on the specific pharmacy, and the legal landscape changed once the FDA declared the shortages over: 503A pharmacies may still compound for an individual patient's documented clinical need (such as a dose or formulation change), but mass-producing copies is restricted. Rules and enforcement are still evolving, so ask your provider how their prescriptions meet current requirements.

Regulators are also watching marketing. In June 2026 the FDA sent a warning letter to altRx's parent company for marketing its compounded semaglutide and tirzepatide in a way that suggested FDA approval - details are in our altRx review.

• Which pharmacy fills it, and is it state-licensed (503A)? A reputable service will name it.
• Is a licensed US clinician reviewing my intake and able to adjust or stop treatment?
• How is it shipped? GLP-1s should arrive cold-chain packed.
• Does any marketing or label say "FDA-approved"? For a compounded product, that is a red flag.
• What happens to my price after a promo or when my dose goes up? (See our breakdown of the real cost of online GLP-1s.)

• If your insurance may cover Wegovy or Zepbound, check that first. A service like ro runs the coverage check and prior authorization for you, and sells only FDA-approved brand-name medication.
• If you want only FDA-approved medication regardless of cost, choose brand-name - it is the only option with FDA review behind it.
• If you are paying cash and brand-name is out of reach, compounded is the realistic route for many people. embody offers compounded semaglutide at $69/mo month-to-month from licensed 503A pharmacies; wellmedr is cheapest long-run if you'll commit to 12 months.
• If you need a non-standard dose, ask about custom dosing - trimrx builds its program around it.
• If you want dietitian access and coaching bundled in, MEDVi includes both in one all-inclusive price.

Not sure which molecule to start on? Read semaglutide vs tirzepatide, or compare every provider in our GLP-1 provider rankings.

This article is general information, not medical advice. A licensed clinician should decide what treatment, if any, is right for you. Results vary.